Thomas H Lanthorn

Title: Thomas H. Lanthorn: Innovator in CNS Disorder Treatments

Introduction

Thomas H. Lanthorn is a notable inventor based in Ballwin, MO (US). He has made significant contributions to the field of medicine, particularly in the treatment of central nervous system (CNS) disorders. His innovative work has led to the development of compounds that hold promise for various cognitive and neurodegenerative conditions.

Latest Patents

Lanthorn holds a patent for "2-amino-4,5-methyleneadipic acid compounds for treatment of CNS disorders." This patent describes compounds, compositions, and methods aimed at treating a range of CNS disorders, including cognitive disorders, epilepsy, depression, Parkinson's disease, Alzheimer's disease, and neurotoxic injuries. The compound of interest is defined by a specific formula, which includes various substituents that enhance its therapeutic potential.

Career Highlights

Throughout his career, Thomas H. Lanthorn has been associated with G.D. Searle & Company, where he has focused on research and development in pharmacology. His work has contributed to advancements in the treatment of CNS disorders, showcasing his commitment to improving patient outcomes through innovative solutions.

Collaborations

Lanthorn has collaborated with notable colleagues, including Roberto Pellicciari and Alexis A. Cordi. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to more effective treatments.

Conclusion

Thomas H. Lanthorn's contributions to the field of CNS disorder treatments exemplify the impact of innovation in medicine. His patented compounds represent a significant step forward in addressing complex neurological conditions.